Industry News
2023 PDA Aseptic Processing of Biopharmaceuticals Conference Report
| Update : 6th November, 2023 |
The two-day 2023 PDA Aseptic Processing of Biopharmaceuticals Conference, held in Incheon, South Korea, provided a unique gathering place for exhibitors and attendees within the Pharma Manufacturing and Quality realm.
The event, held on October 31st and November 1st, was well attended, attracting exhibitors from Asia, China, Europe, and North America. Over 230 attendees were provided with two full days of industry presentations, panel discussions, and valuable networking opportunities.
The PDA conference is one of six held in Asia-Pacific annually.
"PDA’s conferences help us stay up to date on the latest advancements across the pharmaceutical manufacturing industry, better understand the challenges our customers are facing, and connect with industry experts from around the globe."- Ashlee Donaher, Director of Marketing, SmartSkin Technologies.
The conference comprehensively covered industry topics on:
Day1
- Regulatory Agency Perspective
- Annex 1 and CSS Implementation
- Aseptic Processing – Techniques, Technologies & Updates
- Cell & Gene Therapy
Day 2
- Human Error Reduction and Quality Improvement in Aseptic Environment
- Drug Device and Packaging
Panel discussion and Q&A sessions provided further salient points for audience participants and clearly indicated that the speakers and audience alike shared a passion and dedication to the industry.
"The PDA 2023 Conference was well worth the 2-day visit to Songdo, Korea. Top of class expert speakers, and technical sessions for BioPharma manufacturing and innovation, including combination drug and drug/device products.
Excellent review of upcoming regulatory guidelines and industry technical expectations (including MFDS and Annex 1 updates, US FDA QMM and PDA TR-73-2). A global audience, with representation from USA (including the US FDA), Germany, Denmark, Singapore, India, Canada, UK, Taiwan, Korea and the Philippines.
The PDA Asia-Pacific Conference in Korea is truly a global conference with Top of Class technology, science and biologics innovation, in manufacturingand quality disciplines. Very glad I came. And Yes, I will be back in 2024." - Michael Lopez, Chief Executive, HSL BioTechnologies Inc.
The Incheon event is the penultimate this year, with the final conference taking place in Melbourne, Australia (28th to 30th November), including a workshop on day 3.
PDA began hosting conferences and events in Asia-Pacific back in 2018 in Singapore, and the 2024 calendar is already promising some great opportunities to keep up to date with industry case studies, regulation requirements, best practices, trends, and developments:
| 7 - 8 May | Singapore | 2024 PDA Pharmaceutical Manufacturing and Qulaity Conference |
| June | Kuala Lumpur, Malaysia | 2024 PDA QAQC Workshop |
| June | Jakarta, Indonesia | 2024 PDA GMP Workshop |
| 10 -11 July | Tokyo, Japan | 2024 PDA Cell and Gene Pharmaceutical Products Conference |
| 17 - 18 September | Melbourne, Australia | 2024 PDA Asia Pacific Regulatory Conference |
| 29 - 30 October | Incheon, Korea | 2024 PDA Aseptic Processing of Biopharma Conference |
"We look forward to welcoming you all again for more successful events in 2024. See you next year in Asia-Pacific." - Tony Chan, PDA Asia-Pacific Assistant Director
Register your interest for any of next year's events here.
About PDA
The Parenteral Drug Association (PDA) is the leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,500 members worldwide. PDA Asia Pacific provides support to the regional country chapters and hosts annual conferences which aim to bring together top industry experts and thought leaders around the world to raise awareness on issues and technological advancements in the pharmaceutical and biopharmaceutical industries. These events also provide high-quality education on new technical information and regulations.
Source : Cold Chain Platform
